METASTATIC BILIARY TRACT CANCER
Clinical trials for METASTATIC BILIARY TRACT CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BILIARY TRACT CANCER trials appear
Sign up with your email to follow new studies for METASTATIC BILIARY TRACT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets hard-to-treat bile duct cancer
Disease control Recruiting nowThis early-phase trial tests whether adding the experimental drug emavusertib to standard chemotherapy and immunotherapy can help people with advanced bile duct or gallbladder cancer. About 48 adults who have not had prior treatment for their advanced cancer will receive the comb…
Matched conditions: METASTATIC BILIARY TRACT CANCER
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 07:54 UTC
-
New hope for bile duct cancer: experimental drug added to standard therapy
Disease control Recruiting nowThis study tests whether adding an experimental drug called CTX-009 to standard chemotherapy (gemcitabine, cisplatin) and immunotherapy (durvalumab) can help people with advanced bile duct cancer that cannot be removed by surgery. About 50 adults will take part. The main goal is …
Matched conditions: METASTATIC BILIARY TRACT CANCER
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:05 UTC